The unit of this review is Hims Tadalafil + Vardenafil Hard Mints, not the entire Hims catalog. The offer identifies a tadalafil/vardenafil mint described in Hims safety information. Evaluating that treatment means looking at the preparation, evidence, financial commitment and care process together. A strong claim in one area cannot supply missing information in another.
Availability: Documented in the safety library; current sale availability unverified.
The exact product
Product identity comes first because every later claim depends on it. The distinctive issue is two PDE5 inhibitors, including vardenafil. Verify the complete active list and dosage form on the eventual prescription. A provider can sell both approved conventional tablets and compounded preparations, so its brand name does not establish one regulatory category for everything. The table records the advertised option without asserting interchangeability or choosing a dose.
| Provider | Hims |
|---|---|
| Listed active ingredients | Tadalafil + vardenafil |
| Dosage form | Compounded combination mint |
| Regulatory distinction | Compounded preparation; the finished product is not FDA-approved. |
| Source basis | Hims: Hard Mints formulation safety library · Hims: current ED treatment catalog |
Price, supply and payment
The review's price entry is Current plan price not verified. Read the quantity and payment interval beside it before comparing another offer. A per-use price does not establish how many uses must be purchased, and a monthly equivalent can hide a longer upfront commitment. Approximate provider articles should not be presented as confirmed invoices. Ask for the complete selected charge, recurring amount and any fees not included in the headline.
| Public documentation | Hard Mints formulation safety library |
|---|---|
| Current price | Not verified for a matching selectable plan |
| Not 3-in-1 Hard Mints | Different PDE5 pair from sildenafil/tadalafil/B12 |
| Additional assessment | Vardenafil makes rhythm-history review relevant |
What the research can support
The supporting research concerns individual-drug information; sildenafil/tadalafil studies do not test this pair. The unresolved issue is finished-product comparative evidence and account availability. A finished-product conclusion needs evidence that matches the formula, route and outcome being claimed. Ingredient mechanisms and customer satisfaction can generate questions, but they do not automatically establish comparative efficacy. We keep those limits visible instead of turning a complex ingredient list into a numerical quality score.
| Evidence boundary | individual-drug information; sildenafil/tadalafil studies do not test this pair |
|---|---|
| Not established here | finished-product comparative evidence and account availability |
| Clinical and regulatory references | MedlinePlus: Vardenafil · Cui et al. (2015): daily tadalafil with as-needed sildenafil · DailyMed: Tadalafil prescribing information, including section 5.11 · FDA: Compounding and the FDA — questions and answers · MedlinePlus: Sildenafil · MedlinePlus: Tadalafil |
Safety questions for the prescriber
Suitability requires review of the full medication list and health history. Nitrates, recreational nitrites, riociguat, blood-pressure drugs and other ED treatments are relevant, as are cardiovascular and kidney, liver or eye conditions. Do not build a substitute for Hims Tadalafil + Vardenafil Hard Mints by combining separate prescriptions. A formulation decision should come with a rationale and follow-up plan from the responsible clinician.
| Multiple PDE5 inhibitors | Standard tadalafil labeling advises against combining PDE5 inhibitors; individualized rationale and monitoring are needed. |
|---|---|
| Vardenafil | QT/rhythm history and interacting medicines need explicit review. |
Availability and the actual prescription
The availability record is Documented in the safety library; current sale availability unverified. This is a separate question from clinical appropriateness. A product mentioned in public safety information may not have a verified current plan, and a restricted account offering may not be open to new customers. Confirm the exact name and terms before committing to an order or treating a promotional article as an enrollment guarantee.
Refills, changes and cancellation
A complete offer explains what happens after the first shipment. Ask how to report inadequate response, request reassessment and change future orders. The product-specific question is “What evidence and monitoring support this specific two-drug combination?” Distinguish clinical advice from administrative processing, and keep confirmation of both when the prescription changes. A claim that cancellation is easy does not establish that medication already processed will be refunded.
| Next charge | The next order date is the charge/processing date; a first refill can be scheduled early. |
|---|---|
| Cancellation notice | At least 48 hours before the next order, according to support guidance. |
| Already processing | Ending a subscription does not cancel an order already processing or shipped. |
| Refund boundary | No refund guaranteed after pharmacy processing. |
| Policy sources | Hims Support: canceling a subscription · Hims Support: refund policy · Hims Support: when billing occurs |
Compare named products
The related products are useful comparators because they change a concrete feature of this offer. Consider the ingredient list, form, schedule and full charge before comparing speed or convenience. Their inclusion is not a finding that the services provide equivalent patient care. If the needed information is missing, the appropriate result of the review is an unanswered question rather than an invented winner.
Questions to keep with the offer
This is a public-source assessment of Hims Tadalafil + Vardenafil Hard Mints. It includes no patient enrollment, pharmacy inspection, medication assay or measured treatment outcome. The published sources and their access date allow a reader to inspect the basis for each factual entry. A personal decision still requires the accepted quote and the prescribing team's explanation for the actual treatment proposed.
| Ask about this formula | What evidence and monitoring support this specific two-drug combination? |
|---|---|
| Ask about the payment | What are the exact quantity, total due now, renewal amount and notice deadline? |
| Ask about a change | Who confirms the medical instructions, pharmacy order and next account charge? |
When to get urgent help
An erection lasting more than four hours or chest pain requires emergency care. Tell the treating clinician what was taken and when.
Sudden hearing or vision loss needs prompt medical attention. Do not wait for an ordinary account-support reply.
Back to all individual product reviews
Source record
Accessed October 7, 2026. Medical resources and labeling supply general context. Provider-owned pages establish advertised terms, not independently tested outcomes.
- Hims: Hard Mints formulation safety libraryProvider formulation document; includes options not confirmed in the main catalog
- Hims: current ED treatment catalogProvider catalog; individual named offers and starting prices
- MedlinePlus: VardenafilGovernment patient drug information; standard products, not compounded equivalents
- Hims Support: canceling a subscriptionProvider policy; 48-hour notice and orders already processing
- Hims Support: refund policyProvider policy; no guaranteed refund after pharmacy processing
- Hims Support: when billing occursProvider policy; next order date, charge timing, and subscription intervals
- Hims Support: changing the next order dateProvider support; refill rescheduling differs from cancellation
- Cui et al. (2015): daily tadalafil with as-needed sildenafilPrimary clinical study; 180 patients, specific regimen, abstract reviewed via NCBI
- DailyMed: Tadalafil prescribing information, including section 5.11Prescribing label; not evidence for the 4Play combination
- FDA: Compounding and the FDA — questions and answersGovernment guidance on compounded medications
- MedlinePlus: SildenafilDrug information; standard sildenafil products
- MedlinePlus: TadalafilDrug information; standard tadalafil products